reviewTop 1% cited
Patisiran: First Global Approval
Drugs · 2018 · Vol. 78(15) · pp. 1625–1631
Sheridan M. Hoy✉(Springer Nature (New Zealand))
Amyloidosis: Diagnosis, Treatment, OutcomesPeptidase Inhibition and AnalysisEosinophilic Disorders and SyndromesTransthyretinMedicinePolyneuropathyAmyloidosisRNAPharmacologyMessenger RNAInternal medicineBiochemistryBiology
Citations
588
FWCI
20.60
field-weighted impact
References
7
Percentile
100%
vs. same field & year
Citations per year
Cited by
Advances in oligonucleotide drug delivery
Nature Reviews Drug Discovery · 2020 · 1,897 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.